|
Market Closed -
Bombay S.E.
06:21:29 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 417.05 INR | -2.40% |
|
+0.17% | +1.26% |
| 08-03 | Aarti Drugs Limited, Q1 2027 Earnings Call, Aug 03, 2026 | |
| 07-31 | Aarti Drugs Limited Announces Management Changes | CI |
| Market Cap | 38.06B 398M 344M 323M 294M 552M 562M 3.79B 1.48B 19.06B 1.49B 1.46B 63.34B | P/E 2026 |
15x | P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 38.06B 398M 344M 323M 294M 552M 562M 3.79B 1.48B 19.06B 1.49B 1.46B 63.34B | EV / Sales 2026 |
1.14x | EV / Sales 2027 * | 1.29x |
| Free-Float |
40.44% | Yield 2026 * |
0.96% | Yield 2027 * | 1.41% |
Last Transcript: Aarti Drugs Limited
| 22-12-28 | Aarti Drugs : Loss of Share Certificates | PU |
| 22-07-10 | Aarti Drugs : Newspaper Advertisements | PU |
| 1 day | -2.40% | ||
| 1 week | +0.17% | ||
| Current month | -1.52% | ||
| 1 month | +2.52% | ||
| 3 months | +14.91% | ||
| 6 months | +12.35% | ||
| Current year | +1.26% |
| 1 week | 410.4 |  | 453.2 |
| 1 month | 401.25 | | 453.2 |
| Current year | 318.6 | | 453.2 |
| 1 year | 318.6 | | 534.15 |
| 3 years | 312.5 | | 634.9 |
| 5 years | 310.8 | | 648 |
| 10 years | 104.82 | | 1,025 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 80 | - | |
| Chief Executive Officer | 79 | 2007-05-31 | |
Adhish P. Patil
DFI | Director of Finance/CFO | 43 | 2012-07-05 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 79 | 2014-03-31 | |
| Director/Board Member | 62 | 2007-05-31 | |
| Chairman | 80 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.40% | +0.17% | -14.14% | -25.79% | 409M | |
| -2.25% | -0.47% | +72.43% | +119.36% | 1,078B | |
| -0.66% | +0.43% | +49.01% | +50.11% | 632B | |
| -0.54% | +1.39% | +21.88% | +63.83% | 443B | |
| -1.99% | -3.32% | +41.98% | +34.08% | 356B | |
| -1.05% | -2.81% | +24.22% | +34.67% | 289B | |
| -2.12% | -3.67% | -1.09% | +3.11% | 245B | |
| -0.63% | +1.04% | +43.03% | +59.10% | 226B | |
| -1.19% | -3.41% | -9.18% | -52.41% | 204B | |
| +0.16% | +3.87% | +16.25% | +73.27% | 171B | |
| Average | -0.83% | +0.79% | +24.44% | +35.93% | 364.41B | |
| Weighted average by Cap. | -0.08% | +0.31% | +41.44% | +62.22% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 26.07B 273M 235M 221M 201M 378M 385M 2.59B 1.01B 13.05B 1.02B 1B 43.38B | 29.45B 308M 266M 250M 227M 427M 434M 2.93B 1.15B 14.75B 1.16B 1.13B 49.01B |
| Net income | 1.82B 19.05M 16.46M 15.46M 14.06M 26.44M 26.88M 181M 70.85M 912M 71.54M 69.99M 3.03B | 2.15B 22.51M 19.44M 18.27M 16.61M 31.23M 31.75M 214M 83.68M 1.08B 84.5M 82.66M 3.58B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-14 | ₹417.05 | -2.40% | 7,048 |
| 26-08-13 | ₹427.30 | -1.01% | 8,818 |
| 26-08-12 | ₹431.65 | -1.81% | 26,434 |
| 26-08-11 | ₹439.60 | +4.33% | 62,538 |
| 26-08-10 | ₹421.35 | +1.20% | 10,224 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AARTIDRUGS Stock
Select your edition
All financial news and data tailored to specific country editions
